| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Health Care Equipment & Supplies (Health Care sector), LNSR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.12M | - | - | |
| Dir | 568.1K | - | - | |
| COO | 389.2K | - | - | |
| Dir | 263.8K | - | - | |
| CFO | 171.5K | $1.98M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2023 | Weisner Aimee S69 | Director | Buy | 33,353 | $2.56 | $85,488.27 | +778.4% | +39.4% | +64.1% | |
| Dec 7, 2022 | Staab Thomas R II | Chief Financial Officer | Buy | 2,752 | $3.16 | $8,697.46 | +2.1% | -1.9% | -28.5% | |
| Nov 23, 2022 | Winer Gary M53 | Director | Buy | 2,500 | $3.60 | $9,000.00 | +6.7% | -18.5% | -31.8% | |
| Nov 17, 2022 | Winer Gary M53 | Director | Buy | 2,500 | $4.16 | $10,400.00 | +7.2% | -22.4% | -46.6% | |
| Aug 18, 2022 | Winer Gary M53 | Director | Buy | 5,000 | $6.03 | $30,150.00 | +16.9% | -30.2% | -43.6% | |
| Sep 29, 2020 | Pdl Biopharma, Inc. | 10% Owner | Buy | 8,703 | $11.16 | $97,125.48 | +0.1% | - | - |